| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |